Cargando…
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
BACKGROUND: Effects of sodium‐glucose cotransporter 2 inhibitors on reducing hospitalization for heart failure have been reported in randomized controlled trials, but their effects on patients with heart failure with preserved ejection fraction (HFpEF) are unknown. This study aimed to evaluate the d...
Autores principales: | Ejiri, Kentaro, Miyoshi, Toru, Kihara, Hajime, Hata, Yoshiki, Nagano, Toshihiko, Takaishi, Atsushi, Toda, Hironobu, Nanba, Seiji, Nakamura, Yoichi, Akagi, Satoshi, Sakuragi, Satoru, Minagawa, Taro, Kawai, Yusuke, Nishii, Nobuhiro, Fuke, Soichiro, Yoshikawa, Masaki, Nakamura, Kazufumi, Ito, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660815/ https://www.ncbi.nlm.nih.gov/pubmed/32805185 http://dx.doi.org/10.1161/JAHA.119.015103 |
Ejemplares similares
-
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure
por: Ejiri, Kentaro, et al.
Publicado: (2022) -
Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction
por: Nakashima, Mitsutaka, et al.
Publicado: (2021) -
The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2019) -
Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2017) -
Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study
por: Ichikawa, Keishi, et al.
Publicado: (2021)